| Metric | Q3 2024 | Q2 2024 | Q3 2023 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $274M | — | $272M | — | 0.6% |
| Op. Income | $16M | — | -$20M | — | 177.7% |
| Gross Margin | 23.0% | — | 11.0% | — | 12.0pp |
| Net Margin | 6.2% | — | -3.9% | — | 10.1pp |
| EPS (Diluted) | $0.22 | — | $-0.16 | — | 237.5% |
| Free Cash Flow | $135M | — | $135M | — | -0.2% |
| Item | Amount |
|---|---|
| REVENUE | $274M |
| Cost of Revenue | $211M |
| GROSS PROFIT | $63M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $29M |
| SG&A Expenses | $29M |
| Other Expenses | $19M |
| Operating Expenses | $48M |
| Cost & Expenses | $258M |
| OPERATING INCOME | $16M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | $11M |
| INCOME BEFORE TAX | $27M |
| Income Tax Expense | $7M |
| Net Income from Continuing Ops | $19M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $17M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $17M |
| D&A | $3M |
| EBIT | $16M |
| EBITDA | $18M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $274M |
| Cost of Revenue | $211M |
| GROSS PROFIT | $63M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $29M |
| SG&A Expenses | $29M |
| Other Expenses | $19M |
| Operating Expenses | $48M |
| Cost & Expenses | $258M |
| OPERATING INCOME | $16M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | $11M |
| INCOME BEFORE TAX | $27M |
| Income Tax Expense | $7M |
| Net Income from Continuing Ops | $19M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $17M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $17M |
| D&A | $3M |
| EBIT | $16M |
| EBITDA | $18M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $17M |
| Depreciation & Amortization | $3M |
| Stock-Based Compensation | $37M |
| Deferred Income Tax | $7M |
| Other Non-Cash Items | -$5M |
| Change in Working Capital | $79M |
| OPERATING CASH FLOW | $137M |
| Capital Expenditure | -$2M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$129M |
| Sales/Maturities of Investments | $19M |
| Other Investing Activities | $17M |
| NET CASH FROM INVESTING | -$95M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$1M |
| Common Dividends Paid | -$48M |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | -$49M |
| FREE CASH FLOW | $135M |
| Net Change in Cash | -$5M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $145M |
| Short-Term Investments | $0 |
| Net Receivables | $88M |
| Inventory | $0 |
| Other Current Assets | $733.0K |
| TOTAL CURRENT ASSETS | $234M |
| PP&E (Net) | $234M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $188M |
| Tax Assets | $440M |
| Other Non-Current Assets | $57M |
| TOTAL NON-CURRENT ASSETS | $919M |
| TOTAL ASSETS | $1.2B |
| Account Payables | $28M |
| Short-Term Debt | $0 |
| Deferred Revenue | $14M |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $547M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $0 |
| TOTAL NON-CURRENT LIABILITIES | $211M |
| TOTAL LIABILITIES | $758M |
| Common Stock | $852.0K |
| Additional Paid-In Capital | $1.7B |
| Retained Earnings | -$862M |
| Treasury Stock | -$461M |
| Accum. Other Comp. Income | -$2M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $368M |
| Minority Interest | $28M |
| TOTAL EQUITY | $395M |
| TOTAL LIABILITIES & EQUITY | $1.2B |
| Total Debt | $211M |
| Net Debt | $66M |
